Alkaline phosphatase decline and pain response as predictors of overall survival benefit in patients treated with radium-...
Alkaline phosphatase (ALP) declines and pain responses can occur during radium-223 (223Ra) treatment, but their association with treatment outcomes is unclear. For patients with metastatic castration-resistant prostate cancer treated with 223Ra in the …